A phase 1 trial reports a personalised NeoVax vaccine plus nivolumab was feasible and acceptably safe for patients with platinum-sensitive ovarian cancer.
Trending
- Same Perfect Score, Five Times the Price: What a Quality Composite Cannot Say
- Saturn’s Moon Count Jumps to 274 With 128 Confirmations
- Ovarian Cancer Vaccine Paired With Nivolumab Passes First Test
- Skilled Service Can Improve Results From Dryer Repair Austin TX Experts
- How to pick the best SIP app for your long-term goals
- Common Online Lottery Mistakes and How to Avoid Them
- SpaceX Launch Creates Stunning Jellyfish Cloud Over US East Coast
- Continuous Glucose Monitors Help Type 2 Diabetes Patients Stay in Range Longer, Major Trial Finds